Fundraising Fox

Kiniksa

Founded 2015 · 412 employees on LinkedIn · 1 known investors

Kiniksa is a global biopharmaceutical company that discovers and develops novel therapies for patients with unmet medical needs, with a focus on cardiovascular diseases and related conditions. The company has an FDA-approved therapy and multiple clinical-stage assets in its pipeline.

BiotechMedical Devices

Investors · 1

Sofinnova VenturesMenlo Park · $100K – $15M

Competitors · 1

by search overlap
Medscape24 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.

Companies competing with Kiniksa for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Precision Wealth Strategies LLC Buys Shares of 14,063 Kiniksa Pharmaceuticals International, plc $KNSA - Markets Dailythemarketsdaily.com · Jul 2026Kiniksa Pharmaceuticals International PLC (KNSA) Shares Surge 4.7% -- What GF Score of 50 Tells Investorsgurufocus.com · Jul 2026Here's Why You Should Add Kiniksa Stock to Your Portfolio Nowfinance.yahoo.com · Jun 2026Kiniksa's ARCALYST Sales Soar 56%, Funding a Next-Gen Heart Drug Pipeline - BriefGlance.combriefglance.com · Apr 2026

Frequently asked questions

What does Kiniksa do?
Kiniksa is a global biopharmaceutical company that discovers and develops novel therapies for patients with unmet medical needs, with a focus on cardiovascular diseases and related conditions. The company has an FDA-approved therapy and multiple clinical-stage assets in its pipeline.
Who are Kiniksa's investors?
Kiniksa's investors include Sofinnova Ventures.